Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M176,321Revenue (TTM) $M49,436Net Margin (%)13.5Altman Z-Score3.3
Enterprise Value $M193,321EPS (TTM) $2.8Operating Margin %16.7Piotroski F-Score5
P/E(ttm)27.1Beneish M-Score-2.7Pre-tax Margin (%)15.7Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %-2.6Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %-4.1Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow21.0y-y EBITDA Growth Rate %0.9ROA % (ttm)5.1Higher Current Ratio y-yY
Dividend Yield %3.7PEG--ROE % (ttm)9.0Less Shares Outstanding y-yY
Payout Ratio %97.0Shares Outstanding M2,374ROIC % (ttm)7.6Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NVS is held by these investors:

NVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Novartis Bioventures Ltd10% Owner 2014-09-22Buy325,000$15397.4view

Quarterly/Annual Reports about NVS:

    News about NVS:

    Articles On GuruFocus.com
    Jerome Dodson Buys 2 Stocks, Sells 2 in 1st Quarter Apr 17 2017 
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    Novartis Has Bright Future Feb 01 2017 
    2 Top Health Care Dividend Stocks Jan 12 2017 
    7 Stocks With Low P/S Ratios Jan 11 2017 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    Leith Wheeler Investment Funds 3rd Quarter Review Nov 01 2016 
    Eli Lily Leaps Over Patent Hurdles Oct 18 2016 
    The Pharmaceutical Sector Looks Attractive Oct 12 2016 
    Gilead’s Patience Is Wearing Investors' Patience Thin Oct 10 2016 

    More From Other Websites
    Can Novartis' Newest Blockbuster Outperform Again In Q1? Apr 24 2017
    Biotech And Pharma Industry And Stock News Apr 24 2017
    How Lilly's New Drug Could Spark A Deeper Rivalry With Pfizer, Novartis Apr 24 2017
    Analyst Ratings and Recommendations for Novartis Apr 24 2017
    Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS Apr 24 2017
    Novartis Tests New Alzheimer’s Drug on People Who Don’t Have the Disease Apr 23 2017
    Should Gilead Sciences Be Worried About Allergan? Apr 23 2017
    Novartis’s 1Q17 Estimates: Innovative Medicines Segment Apr 21 2017
    Analysts Expect Novartis’s Revenues to Remain Flat in 1Q17 Apr 21 2017
    Analyst Estimates for Novartis’s 1Q17 Earnings Apr 21 2017
    Three Hot Junior Biotech Plays Apr 21 2017
    Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL Apr 21 2017
    An Alcon Sale Will Take a Bargain Price Apr 20 2017
    Novartis (NVS) Q1 Earnings: Will the Stock Disappoint? Apr 20 2017
    Novartis AG : NVS-US: Dividend Analysis : March 03rd, 2017 (record date) : By the numbers : April... Apr 19 2017
    Allergan (AGN) Collaborates with Novartis to Treat NASH Apr 19 2017
    Novartis' (NVS) CTL109 BLA Gets Breakthrough Therapy Status Apr 19 2017
    Could Lilly Outperform These Bigger Rivals On Strong Diabetes Meds? Apr 18 2017
    Why the Ionis Spinoff Will Be a Win for Long-Term Investors Apr 18 2017
    Novartis Predicts Chinese Drug Market Growth Will Accelerate Apr 18 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)